Nasdaq
Trinity Biotech Regains Nasdaq Compliance
The firm had received notice last year that it was out of compliance with a requirement to maintain a minimum $15 million market value of publicly held shares.
Nasdaq to Delist Centogene
The German firm did not appeal the decision and will be delisted after having failed to achieve certain milestones to retain its status as a listed company.
OpGen Shares Suspended From Trading on Nasdaq
The suspension comes as the molecular diagnostics firm struggles to meet the Nasdaq's minimum stockholders’ equity requirement.
Centogene Delisted From Nasdaq
The German rare disease company expects its common stock to begin trading on the OTC Markets Group platform on Aug. 8 under the ticker symbol CNTGF.
360Dx Top 30 Jumps 11 Percent in July
Of the 30 companies in the index, 27 saw their share prices increase, while three saw their stock prices decline.
May 16, 2024
OpGen to Execute 1-for-10 Reverse Stock Split
Apr 24, 2024
Nasdaq Warns OpGen About Overdue 2023 Annual Report
Apr 17, 2024
DermTech Receives Delisting Warning From Nasdaq
Mar 1, 2024
360Dx Top 30 Creeps up 1 Percent in February
Jan 7, 2024
LumiraDx Shares to be Delisted From Nasdaq
Jan 4, 2024
Burning Rock Receives Nasdaq Delisting Warning
Dec 13, 2023
OpGen Requests Hearing on Nasdaq Delisting
Nov 27, 2023